Posts by Brian Burns
Benchmarks: Mass General Research News and Notes for August 9, 2024
Study shows trust in doctors, hospitals declined during the COVID era, more info on the protective effect of aspirin in colorectal cancer & more.
Read MoreFive Things to Know: The Risk of Head and Neck Injuries from Olympic-Style Sports
Past research has shown there are short- and long-term increases in layperson sports participation coinciding with the Olympic games
Read MoreCongratulations to the 2024 Winners of the Claflin Distinguished Scholar Awards
The Claflin awards were established at Mass General to recognize and support women researchers during a critical time in their careers.
Read MoreBenchmarks: Mass General Research News and Notes for July 26, 2024
Study shows disparities between male and female surgical residents in experiences of pregnancy and parenthood, the tweets of the week & more.
Read MoreSnapshot of Science: Mass General’s High Impact Research Publications for June 2024
New insights from Mass General researchers in the areas of cancer, rare diseases genetics, heart health and much more.
Read MoreCongratulations to the 2024 Class of the Bridging Academia and Industry Education Program
The program seeks to create a shared culture of “innovation through collaboration” among investigators from academia and industry.
Read MorePilot Study Shows Promise of Virtual Reality in Improving Treatment Outcomes for Opioid Withdrawal
Patients who participated in a virtual reality intervention during treatment for opioid withdrawal were more likely to complete their treatment protocol.
Read MoreHow Malnourished Organoids Could Play a Key Role in the Quest for a Vaccine Against Shigella
Mass General researcher Christina Faherty, PhD, is using creative techniques to better understand the mechanisms of shigella infection.
Read MoreThe Astonishing Team Effort that Led to the First Trial of CAR T Cells for Glioblastoma at Mass General Brigham
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Read MoreRare Diseases Day: Q&A with a Mass General Investigator
Vanessa Merker,PhD, has spent her 14-year career at Mass General working to improve care for patients with schwannomatosis and NF2.
Read More